Indefinite Delivery Contract HHSN268201600013I

The National Institutes of Health (NIH) Clinical Center awarded a single-award Indefinite Delivery Contract (IDC) to Miltenyi Biotec, Inc., a global biotechnology company, to provide proprietary CliniMACS cell isolation reagents and consumables. The $4.6 million contract has an initial base period through September 2025, with options to extend to 2027. This sole-source contract ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing...

The American Type Culture Collection (ATCC), a nonprofit biological resource center, has been awarded an Indefinite Delivery Contract (IDC) by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency. The contract has a ceiling value of $250,000,000 and a period of performance through August 21, 2025. Under this IDC, ATCC will provide a broad range of specialized biological services and support to ASPR, including storage and distribution of biological...

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Cedars-Sinai Medical Center, a nonprofit hospital and academic medical center located in Los Angeles. The $22,113 contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the NCI's efforts related to the American Recovery and Reinvestment Act (ARRA)....

The Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) has awarded a single-award indefinite delivery contract to Polypeptide Laboratories San Diego, LLC, a Contract Development & Manufacturing Organization (CDMO), to provide chemistry, manufacturing, and controls (CMC) services for the development of drug substances. This five-year, $49.7 million IDV contract, awarded without set-asides, supports NCATS'...

The Department of Health and Human Services' National Center for Advancing Translational Sciences (NCATS) has issued a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to $49,885,703 to support Chemistry, Manufacturing, and Control (CMC) services for drug product development. The 7-year contract was awarded to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract scope includes a wide range of CMC services...

The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) has awarded a $20 billion Indefinite Delivery Contract to Advanced Technology International (ATI), a public service nonprofit, to establish and manage the Biopharmaceutical Manufacturing Preparedness Consortium (BIOMAP-Consortium). The consortium aims to build domestic manufacturing capabilities for medical countermeasures like vaccines, therapeutics, and personal...

The Department of Health and Human Services Food and Drug Administration awarded a blanket purchase agreement to Charles River Laboratories, Inc. to provide various research services including embryo and sperm cryopreservation, housing expansion, and special air freight. Under three call orders against the agreement, Charles River will deliver embryo cryopreservation procedures for $1,500-$2,266.80 each, totaling $36,468, as well as sperm cryopreservation services for $28,565.60. Special air...

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $178,230 firm fixed-price delivery order is for the recovery and delivery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is part of the agency's efforts to characterize the genomic changes in cancer....

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) as the prime contractor. The contract, valued at $41,000, is for the delivery of tissue samples and data from various cancer types to support the Cancer Genome Atlas (TCGA) program, a collaborative effort to comprehensively map the genetic changes in various types of cancer. This contract...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Mayo Clinic, a renowned non-profit academic medical center. The contract, valued at $130,403.07, supports the NCI's Cancer Genome Atlas (TCGA) program by recovering tissue samples and data from various types of cancer. It is part of a larger $9.9 million NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract, which allows the NCI to efficiently...